Seres Therapeutics Statistics
Total Valuation
MCRB has a market cap or net worth of $83.21 million. The enterprise value is $116.96 million.
Important Dates
The next estimated earnings date is Wednesday, May 6, 2026, before market open.
| Earnings Date | May 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MCRB has 9.59 million shares outstanding. The number of shares has increased by 14.16% in one year.
| Current Share Class | 9.59M |
| Shares Outstanding | 9.59M |
| Shares Change (YoY) | +14.16% |
| Shares Change (QoQ) | +5.22% |
| Owned by Insiders (%) | 0.60% |
| Owned by Institutions (%) | 11.66% |
| Float | 7.28M |
Valuation Ratios
The trailing PE ratio is 13.56.
| PE Ratio | 13.56 |
| Forward PE | n/a |
| PS Ratio | 101.09 |
| Forward PS | n/a |
| PB Ratio | 1.80 |
| P/TBV Ratio | 1.80 |
| P/FCF Ratio | 92.21 |
| P/OCF Ratio | 71.40 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 20.53 |
| EV / Sales | 148.24 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 135.21 |
Financial Position
The company has a current ratio of 2.56, with a Debt / Equity ratio of 1.88.
| Current Ratio | 2.56 |
| Quick Ratio | 2.40 |
| Debt / Equity | 1.88 |
| Debt / EBITDA | n/a |
| Debt / FCF | 95.91 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 19.64% and return on invested capital (ROIC) is -50.50%.
| Return on Equity (ROE) | 19.64% |
| Return on Assets (ROA) | -42.25% |
| Return on Invested Capital (ROIC) | -50.50% |
| Return on Capital Employed (ROCE) | -79.05% |
| Weighted Average Cost of Capital (WACC) | 2.79% |
| Revenue Per Employee | $11,955 |
| Profits Per Employee | $86,303 |
| Employee Count | 66 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -22.39% in the last 52 weeks. The beta is 0.26, so MCRB's price volatility has been lower than the market average.
| Beta (5Y) | 0.26 |
| 52-Week Price Change | -22.39% |
| 50-Day Moving Average | 9.95 |
| 200-Day Moving Average | 14.76 |
| Relative Strength Index (RSI) | 38.98 |
| Average Volume (20 Days) | 45,701 |
Short Selling Information
The latest short interest is 597,314, so 6.23% of the outstanding shares have been sold short.
| Short Interest | 597,314 |
| Short Previous Month | 628,417 |
| Short % of Shares Out | 6.23% |
| Short % of Float | 8.20% |
| Short Ratio (days to cover) | 9.26 |
Income Statement
In the last 12 months, MCRB had revenue of $789,000 and earned $5.70 million in profits. Earnings per share was $0.64.
| Revenue | 789,000 |
| Gross Profit | -54.82M |
| Operating Income | -93.97M |
| Pretax Income | 5.70M |
| Net Income | 5.70M |
| EBITDA | -89.84M |
| EBIT | -93.97M |
| Earnings Per Share (EPS) | $0.64 |
Full Income StatementBalance Sheet
The company has $45.77 million in cash and $82.97 million in debt, with a net cash position of -$37.20 million or -$3.88 per share.
| Cash & Cash Equivalents | 45.77M |
| Total Debt | 82.97M |
| Net Cash | -37.20M |
| Net Cash Per Share | -$3.88 |
| Equity (Book Value) | 44.22M |
| Book Value Per Share | 4.63 |
| Working Capital | 30.05M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $1.12 million and capital expenditures -$252,000, giving a free cash flow of $865,000.
| Operating Cash Flow | 1.12M |
| Capital Expenditures | -252,000 |
| Depreciation & Amortization | 4.13M |
| Net Borrowing | n/a |
| Free Cash Flow | 865,000 |
| FCF Per Share | $0.09 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -11,910.14% |
| Pretax Margin | 721.93% |
| Profit Margin | 721.93% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | 109.63% |
Dividends & Yields
MCRB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -14.16% |
| Shareholder Yield | -14.16% |
| Earnings Yield | 7.14% |
| FCF Yield | 1.08% |
Analyst Forecast
The average price target for MCRB is $14.00, which is 61.29% higher than the current price. The consensus rating is "Buy".
| Price Target | $14.00 |
| Price Target Difference | 61.29% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
Stock Splits
The last stock split was on April 22, 2025. It was a reverse split with a ratio of 1:20.
| Last Split Date | Apr 22, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
MCRB has an Altman Z-Score of -11.02 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -11.02 |
| Piotroski F-Score | 3 |
